Gene amplification of RUNX2 and its frequent protein expression in human osteosarcoma

Chinese Journal of Clinical Oncology

Volumn 40, Issue 7, 2013, Pages 398-402

  Zhao, Linru ^a   Zheng, Hong ^a   Yang, Jilong ^a   Tian, Wei ^a   Pan, Yi ^a   Wang, Guowen ^a   Liao, Zhichao ^b   Chen, Kexin ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

aCGH; Gene amplification; Osteosarcoma; Runt related transcription factor 2 RUNX2

Indexed keywords

TRANSCRIPTION FACTOR RUNX2;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; METASTASIS; OSTEOSARCOMA; OVERALL SURVIVAL; PATHOGENESIS; PROTEIN EXPRESSION;

EID: 84879473691     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2013.07.007     Document Type: Article

References (15)

1. Hameed M, Dorfman H. Primary malignant bone tumors - recent developments[J]. Semin Diagn Pathol, 2011, 28(1):86-101.
2. Komori T, Yagi H, Nomura S, et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts[J]. Cell, 1997, 89(5):755-764. (Pubitemid 27516178)
3. Enomoto H, Furuichi T, Zanma A, et al. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro[J].J Cell Sci, 2004, 117(3):417-425. (Pubitemid 38181203)
4. San Martin IA, Varela N, Gaete M, et al. Impaired cell cycle regulation of the osteoblast-related heterodimeric transcription factor Runx2-Cbfbeta in osteosarcoma cells[J]. J Cell Physiol, 2009, 221(3):560-571.
5. Nathan SS, Pereira BP, Zhou YF, et al. Elevated expression of Runx2 as a key parameter in the etiology of osteosarcoma[J]. Mol Biol Rep, 2009, 36(1):153-158.
6. Eliseev RA, Dong YF, Sampson E, et al. Runx2-mediated activation of the Bax gene increases osteosarcoma cell sensitivity to apoptosis[J]. Oncogene, 2008, 27(25):3605-3614. (Pubitemid 351793799)
7. Pratap J, Lian JB, Javed A, et al. Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone[J]. Cancer Metastasis Rev, 2006, 25(4):589-600. (Pubitemid 46071865)
8. Yang J, Cogdell D, Yang D, et al. Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma[J]. Cancer Lett, 2010, 291(1):31-38.
9. Won KY, Park HR, Park YK. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma[J]. Tumori, 2009, 95(3):311-316.
10. Kurek KC, Del Mare S, Salah Z, et al. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression[J]. Cancer Res, 2010, 70(13):5577-5586.
11. Squire JA, Pei J, Marrano P, et al. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays[J]. Genes chromosomes cancer, 2003 38(3):215-225. (Pubitemid 37259638)
12. Sadikovic B, Yoshimoto M, Chilton-MacNeill S, et al. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling[J]. Hum Mol Genet, 2009, 18(11):1962-1975.
13. Drissi H, Luc Q, Shakoori R, et al. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene[J]. J Cell Physiol, 2000, 184(3):341-350. (Pubitemid 30625497)
14. Walkley CR, Qudsi R, Sankaran VG, et al. Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease[J]. Genes Dev, 2008, 22(12):1662-1676. (Pubitemid 351846845)
15. Lengner CJ, Steinman HA, Gagnon J, et al. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling[J]. J Cell Biol, 2006, 172(6):909-921.